Skip to main content
OpenTrials
Completed

NCT Number: NCT00644085

Does Low-Dose Aspirin Improve Outcome in In Vitro Fertilisation/Intra Cytoplasmatic Sperm Injection (IVF/ICSI)?

To investigate the effect of daily administration of low-dose aspirin, compared to placebo, on IVF and ICSI outcome.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Infertility Genital Diseases Urogenital Diseases

Sex eligibility

Female

Study type

Interventional

Phase

Phase 3

Primary location

University Hospital Ghent

Ghent, 9000, Belgium

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Dutch-speaking women
  • Starting a first or second IVF/ICSI cycle

Exclusion criteria

  • Women suffering from
  • platelet dysfunction
  • thrombopenia
  • gastro-intestinal ulcers
  • recurrent gastritis
  • aspirin hypersensitivity
  • Women on treatment with anticoagulants or aspirin

Treatment and study plan

Aspirin

Drug

oral administration of aspirin 100 mg

Placebo

Drug

oral administration of placebo

Primary outcomes

  1. Number of oocytes retrieved

  2. Clinical pregnancy rate per embryo transfer

Secondary outcomes

  1. Live birth rate per cycle

Sponsors and collaborators

Lead sponsor

University Hospital, Ghent

Other

Registry information

Official study title

Does Low-Dose Aspirin Improve Outcome in IVF/ICSI? A Prospective, Randomized, Double Blind Placebo Controlled Trial

Important dates

Study start
2000
Study completion
2007
First posted
Mar 26, 2008
Registry last updated
Mar 28, 2008

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.